CLSA-Championed Legislation Introduced in Congress to Improve Access to Breakthrough Medical Devices

May 7, 2016

On April 20, Representatives Tony Cárdenas (D-Van Nuys), Charles Boustany (R-La.), Richard Neal (D-Mass.) and Gus Bilirakis (R-Fla.) introduced H.R. 5009, the Ensuring Patient Access to Critical Breakthrough Products Act, legislation that would streamline Medicare coverage for technologies approved through the FDA’s medical device expedited review process.

CLSA strongly supports this bill to modernize Medicare coverage and payment policies, ultimately improving timely patient access to innovative, breakthrough technologies. Working in close collaboration with AdvaMed and our member companies, CLSA’s advocacy and engagement efforts highlighted the importance of such reforms for California’s innovative medical technology sector, and were critical for securing California Rep. Cárdenas as an original co-author of the legislation.

CLSA is also leading support for the measure through a multi-state/regional life sciences association letter of endorsement, and we will co-host a congressional staff briefing to educate key members of Congress on this legislation and the broader importance of pro-innovation, pro-patient coverage and payment policies.

CLSA’s endorsement letter of the legislation is available here. Click here to view CLSA’s press release lauding the legislation.

For questions, please contact Jenny Carey, CLSA’s Vice President of Federal Government Relations and Alliance Development (